Treatment of Shoulder Capsulitis by single or Multiple Corticosteroid Injections

South Eastern Health and Social Care Trust0 个研究点开始时间: 2007年8月1日最近更新: 2012年3月19日

适应症

试验速览

暂无简介。

•Adult subjects (>= 18 years) with unilateral shoulder pain of more than 4 weeks duration and a SPADI score of >= 30 as this represents significant disability. Shoulder pain is defined as pain in the shoulder region, including the upper arm, elicited by shoulder movement. Capsulitis” is defined by finding of limitation of passive range of movement of greater than 25% in both external rotation and abduction as compared with the contra-lateral shoulder with relatively more restriction in external rotation than abduction and internal rotation.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•Physiotherapy or injection treatment for current shoulder pain in previous 3 months
•inability to give informed consent
•blood coagulation disorders
•bilateral shoulder pain
•abnormal shoulder X-ray defined as significant glenohumeral or subacromial joint space narrowing suggesting OA of glenohumeral joint or complete RC rupture,
•evidence of rotator cuff tear, tested by external rotation lag sign, drop sign, internal rotation lag sign and static muscle resistance in external rotation, internal rotation and abduction,
•history of significant trauma to the shoulder,
•inflammatory joint disease,
•history of cerebrovascular accident,
•allergy or contraindication to Triamcinolone/contraindication to injection.
•evidence of referred pain from cervical spine disease.
•pregnancy or breast feeding

发起方